Literature DB >> 11808925

Update: investigation of bioterrorism-related inhalational anthrax--Connecticut, 2001.

.   

Abstract

Since October 3, 2001, CDC and state and local public health authorities have been investigating cases of bioterrorism-related anthrax. As of November 28, a total of 23 cases have been identified; 11 were confirmed as inhalational anthrax, and 12 (seven confirmed and five suspected) were cutaneous. Epidemiologic investigations to identify the source of exposure to Bacillus anthracis continue for a case of inhalational anthrax in a hospital stockroom worker in New York City (NYC) and, most recently, a case of inhalational anthrax in an elderly woman in Connecticut (CT). Antimicrobial prophylaxis is continuing in persons exposed to B. anthracis, and surveillance to detect new cases of bioterrorism-related anthrax is ongoing. This report summarizes the findings of the case investigation in CT.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11808925

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  19 in total

1.  Validation of a pXO2-A PCR assay to explore diversity among Italian isolates of Bacillus anthracis strains closely related to the live, attenuated Carbosap vaccine.

Authors:  M Muscillo; G La Rosa; M Sali; E De Carolis; R Adone; F Ciuchini; A Fasanella
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

2.  Operational evaluation of high-throughput community-based mass prophylaxis using Just-in-time training.

Authors:  James D Spitzer; Nathaniel Hupert; Jonathan Duckart; Wei Xiong
Journal:  Public Health Rep       Date:  2007 Sep-Oct       Impact factor: 2.792

3.  Night of two town meetings.

Authors:  Mattew L Cartter
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

4.  Inhalation anthrax: dose response and risk analysis.

Authors:  Margaret E Coleman; Brandolyn Thran; Stephen S Morse; Martin Hugh-Jones; Stacey Massulik
Journal:  Biosecur Bioterror       Date:  2008-06

5.  The pitfalls of bioterrorism preparedness: the anthrax and smallpox experiences.

Authors:  Hillel W Cohen; Robert M Gould; Victor W Sidel
Journal:  Am J Public Health       Date:  2004-10       Impact factor: 9.308

6.  Pathology and pathogenesis of bioterrorism-related inhalational anthrax.

Authors:  Jeannette Guarner; John A Jernigan; Wun-Ju Shieh; Kathleen Tatti; Lisa M Flannagan; David S Stephens; Tanja Popovic; David A Ashford; Bradley A Perkins; Sherif R Zaki
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

7.  Recruiting primary care clinicians for public health and bioterrorism surveillance.

Authors:  Jonathan L Temte; Michael E Grasmick
Journal:  WMJ       Date:  2009-04

8.  Anthrax postexposure prophylaxis in postal workers, Connecticut, 2001.

Authors:  Jennifer L Williams; Stephanie S Noviello; Kevin S Griffith; Heather Wurtzel; Jennifer Hamborsky; Joseph F Perz; Ian T Williams; James L Hadler; David L Swerdlow; Renee Ridzon
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

9.  Environmental sampling for spores of Bacillus anthracis.

Authors:  Eyasu H Teshale; John Painter; Gregory A Burr; Paul Mead; Scott V Wright; Larry F Cseh; Ronald Zabrocki; Rick Collins; Kathy A Kelley; James L Hadler; David L Swerdlow
Journal:  Emerg Infect Dis       Date:  2002-10       Impact factor: 6.883

10.  Bioterrorism-related inhalational anthrax in an elderly woman, Connecticut, 2001.

Authors:  Kevin S Griffith; Paul Mead; Gregory L Armstrong; John Painter; Katherine A Kelley; Alex R Hoffmaster; Donald Mayo; Diane Barden; Renee Ridzon; Umesh Parashar; Eyasu Habtu Teshale; Jennifer Williams; Stephanie Noviello; Joseph F Perz; Eric E Mast; David L Swerdlow; James L Hadler
Journal:  Emerg Infect Dis       Date:  2003-06       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.